<DOC>
	<DOCNO>NCT01088399</DOCNO>
	<brief_summary>The Hypopituitary Control Complications Study `` HypoCCS '' prospective , open label , global , multicentre , observational study routine clinical care adult growth hormone deficiency occur either isolated combination pituitary hormone deficiency . The objective observational study evaluate long-term safety health outcome adult growth hormone deficient participant without somatropin replacement therapy . As observational study , data collect provided discretion attend physician . The participant enrol meet criterion growth hormone deficiency adult per Humatrope label country attend physician practice , diagnosis discretion attend physician . The decision receive somatropin remain untreated make participant consultation attend physician . While treatment adult growth hormone deficient participant somatropin show safe effective clinical trial 18 month duration , observational study aim provide information health outcome replacement therapy long period time large number participant context overall disease environment .</brief_summary>
	<brief_title>A Prospective Observational Study Effect Somatropin Growth Hormone Deficient Adults</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hypopituitarism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Adult growth hormone deficiency per local Humatrope label judge attend physician As per local Humatrope label judge attend physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>